| Funding Opportunity ID: |
324998 |
| Opportunity Number: |
CDC-RFA-GH20-2074 |
| Opportunity Title: |
Optimizing HIV Clinical and Laboratory HIV Services at a National Referral Level Hospital in Support of the National Level HIV Program to Attain Epidemic Control in Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.067 |
| Eligible Applicants: |
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
Eligible applicants that can apply for this NOFO are: University Teaching Hospital (UTH). |
| Agency Code: |
HHS-CDC-CGH |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control – CGH |
| Posted Date: |
Mar 02, 2020 |
| Close Date: |
May 01, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Last Updated Date: |
Mar 02, 2020 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$0 |
| Expected Number of Awards: |
1 |
| Description: |
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $12,000,000 for Year 1, subject to the availability of funds. This NOFO aims to optimize HIV clinical and laboratory service delivery at the national referral level hospital and other provincial level referral facilities. Activities funded through this NOFO will improve HIV service delivery and provide national, provincial, district, and site level technical support to the Ministry of Health (MOH). The main goal is to provide high quality comprehensive facility/hospital based, clinical and laboratory services for in- and out-patients at specified referral health centers in Zambia. The recipient will also provide technical expertise and support to the national antiretroviral therapy (ART) program to develop, monitor and attain targets, develop and provide strategic guidance, set standards and enable timely response to the latest emerging global, regional, and locally derived evidence. The scope of work will cover all aspects of HIV prevention, testing, treatment, clinical support, laboratory, and other monitoring for general, priority, and key populations. Additionally, the recipient will provide services for individuals who have experienced sexual gender-based violence (GBV), including child sexual abuse (CSA). |
| Version: |
1 |
|
